Member Info for Kaeren

Memory definitely hazy , Ncyt owed another 80 million.

https://twitter.com/gggg2120/status/1582020848327610368?s=20&t=38dwL2FaNUaIKB_cn0jXNg

Tata medical and Diagnostics is a 100 % subsidiary of Tata sons , huge brand and no issue with financing anything if it lucrative imo

https://www.tata.com/business/tata-medical-diagnostics

We all know about antibiotic resistance and how we have to minimise use. Find it remarkable the new health sec admits to doling out antibiotics to mate's, she isn't a doctor , where did she get them and is she aware of drug interactions like Ciprofloxin cannot be taken with statins. I certainly wouldn't be taking medical advice off her , reported ( unsure of accuracy) that she was kicked out of Oxford for failing chemistry exams.

https://twitter.com/thetimes/status/1581231199380336641?s=20&t=bxPT2P7Qoyf2CtyqhDNXQg

Welsh , they are our instruments white labelled , they didn't start to push them until June , so too early to tell what the fiscal implications will be. However I would like to see some evidence of tests being sold and not just the machines as obviously that is the money generator.

WILSON
https://twitter.com/TopTradersADVFN/status/1581005868060921856?s=20&t=yyDmckiTxth7KQwLILhAbg

I was commenting on MM's, not the market and some pi's wanting to see cash. No idea what motivates pi A versus B , personally more then happy with all I've read/ heard thus far.

MM don't give a fkying fig about seeing seeing cash , they aren't investing .

If James gets revenue forecasts wrong again he should take a long walk off a short pier !

Harchris I hear you . However it begs a question , why not phrase it that the company will continue to push its huge arsenal of covid products and avail of any opportunities that present themselves, as we believe blah blah. Having spent so much time , effort and money on covid products and bioinformatic automation I find it a trite odd, It would appear with multiple variants surfacing everywhere that testing demand may well increase. Germany for example has reintroduced testing for all patients and visitors to care homes and hospitals already. The safe thing to do to manage expectations is to discount any revenue from sales of covid products , but I would question why if testing does take off again. Just my personal thoughts.

Not particularly surprised, can think of many ' holders' who could have contacted Alex with a tip off , which is not a tip off with any new information or anything the govt or Novacyt have said , let's be realistic here, the sp was going the wrong way for some 'holders' I'm off out for the day. Will catch up later.

No info released , no comment from Nova or govt at any stage on this.

"The report was kept in draft form as publication would have had “adverse commercial consequences” for Primerdesign."
I suspect another tip off to Alex , makes absolutely no sense . No way if a test was producing false negatives would it have been allowed to remain for sale and the govt say nothing because it would hurt Novacyt financially , that would be beyond irresponsible of the UK govt and a big f off to all purchasing it. Yes CTDA approved..

Yep spending and growing.

I was reading Rdsimpleguide. Don't know how to carry to board as it won't allow me to copy the link.

I was reading the HMRC simple guide ( didn't find it simple ) and realise we qualify under staff numbers but not turnover and balance , but am failing to understanding what regs apply to us as ' large company ' and realise potentially we could qualify as a small company , was particularly interested in the very high relief for losses.

Just been trying to have a read about quite extensive changes to tax relief for companies involved in R&D. Major changes from April 2023, any tax experts who can explain ?

This guy has the answers Giz

https://twitter.com/BearBullTraders/status/1578144010241478656?s=20&t=rjuIc-ZPJPb_qgQoFDGajw

See you posted as I was typing Drb.

Well aware our case is nothing to do with GLP DRB83 , however the last thing we need is to have a case launched that the contract was not handed out following established protocols and secondly Abingdon have been successful in obtaining payment from the government. Those are the two reasons many holders of shares who are in dispute with rhe DHSC will have been following this case closely.
Little Abingdon got its wonga! Good for them , the last 1.5mm held back until outcome of this case will now be paid.